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The protein kinase Akt/PKB participates in a great variety of processes, including
translation, cell proliferation and survival, as well as malignant transformation and viral
infection. In the last few years, novel Akt posttranslational modifications have been
found. However, how these modification patterns affect Akt subcellular localization,
target specificity and, in general, function is not thoroughly understood. Here, we
postulate and experimentally demonstrate by acyl-biotin exchange (ABE) assay and 3H-
palmitate metabolic labeling that Akt is S-palmitoylated, a modification related to protein
sorting throughout subcellular membranes. Mutating cysteine 344 into serine blocked
Akt S-palmitoylation and diminished its phosphorylation at two key sites, T308 and
T450. Particularly, we show that palmitoylation-deficient Akt increases its recruitment
to cytoplasmic structures that colocalize with lysosomes, a process stimulated during
autophagy. Finally, we found that cysteine 344 in Akt1 is important for proper its function,
since Akt1-C344S was unable to support adipocyte cell differentiation in vitro. These
results add an unexpected new layer to the already complex Akt molecular code,
improving our understanding of cell decision-making mechanisms such as cell survival,
differentiation and death.
Keywords: Akt, S-palmitoylation, cell signaling, subcellular localization, Golgi, lysosomes, autophagy, cell
differentiation
INTRODUCTION
To process external and internal information, cells have evolved a multiplicity of signaling systems.
At least 15% of the vertebrate’s genome protein coding capability is linked to receptors, components
of signaling systems and transcription regulatory proteins and their dysfunction is associated with
several pathologies (Koonin et al., 2004). In the case of cancer, changes in the function of signaling
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systems are so important that they are utilized to define and
classify different types of tumors (Hanahan and Weinberg, 2011).
Signaling pathways often transduce information through
phosphorylation events mediated by protein kinases. Akt (also
known as protein kinase B or PKB), a serine/threonine
protein kinase member of the AGC family, is vastly studied
as a model of how signaling proteins transduce and process
extracellular information into cell decisions and fates (Staal, 1987;
Blaustein, 2018). Akt plays a central role in growth, proliferation,
glucose uptake, metabolism, angiogenesis, protein translation,
cell survival as well as in viral infection (Diehl and Schaal,
2013; Manning and Toker, 2017). Not surprisingly, a variety
of human cancers exhibit dysregulated Akt activity and several
mouse models with activated Akt develop cancer (Altomare and
Testa, 2005; Toker and Yoeli-Lerner, 2006; Riggio et al., 2012).
Thus, it is not surprising that different clinical trials are underway
to test the efficacy of a variety of inhibitors of the Akt pathway as
anticancer and antiviral treatments (Dunn et al., 2009; Okuzumi
et al., 2009).
Akt contains an N-terminal pleckstrin homology (PH)
domain that interacts with phosphatidylinositol (3,4,5)-
triphosphate (PIP3) (Andjelkovic et al., 1997; Franke et al.,
1997), a central kinase domain and a C-terminal domain that
contains an hydrophobic motif (HM) with homology to other
AGC kinases (Alessi et al., 1996). There are three isoforms
of Akt in mammals (Akt1, Akt2, and Akt3), each transcribed
from a separate gene (Jones et al., 1991a,b; Konishi et al.,
1995; Brodbeck et al., 1999). Traditional activation of all Akt
isoforms is triggered when class I phosphatidylinositol-3-kinase
(PI3K), which converts plasma membrane (PM) associated
phosphatidylinositol-4,5-bisphosphate (PIP2) to PIP3, is
recruited by activated receptor tyrosine kinases (Geering et al.,
2007). Cytosolic Akt then relocalizes to the PM by binding to
PIP3, allowing its phosphorylation at T308 (T309 and T305 in
Akt2 and AktT3, respectively) by Phosphoinositide-Dependent
Kinase-1 (PDK1) and at S473 (S474 and S472 in Akt2 and
Akt3, respectively) by the mammalian target of rapamycin
complex 2 (mTORC2) (Alessi et al., 1997; Sarbassov et al., 2005).
Interestingly, recent findings show that phosphatidylinositol-
3,4-bisphophate (PI34P2), also produced by PI3K, selectively
recruits Akt2 at both the PM and early endosomes, whereas PIP3
specifically binds to Akt1 and Akt3 at the PM (Liu et al., 2018).
Different groups have shown that Akt can be phosphorylated
in several residues other than T308 and S473 (Risso et al.,
2015; Manning and Toker, 2017). In addition, Akt undergoes
other posttranslational modifications (PTMs): O-glycosylation,
ubiquitination, acetylation, oxidation and SUMOylation (Park
et al., 2005; Yang et al., 2009; Sundaresan et al., 2011; Wani et al.,
2011a,b; Risso et al., 2013), highlighting that regulation of Akt
activity is exceptionally complex (Risso et al., 2015; Manning
and Toker, 2017). Recently, it was also demonstrated that
Akt is proline-hydroxylated (Guo et al., 2016) and methylated
(Yoshioka et al., 2016; Guo et al., 2019; Wang et al., 2019).
If all the reported Akt PTMs were independent from each
other, the number of potential states of Akt would be larger
than one hundred million (a number that is even higher if the
three Akt paralogues and their splicing isoforms are taking into
account). In addition, Akt has been associated with a number of
subcellular destinations: activated Akt acts on multiple targets
located in the PM, cytosol and nucleus. Remarkably, Akt was
also found (presumably on the cytosolic side) in other subcellular
compartments such as mitochondria, endoplasmic reticulum
(ER) and lysosomes (Hosoi et al., 2007; Santi and Lee, 2010; Arias
et al., 2015). Consistently, several Akt substrates and functions
have been reported to be associated with newly described Akt
subcellular destinations (Mounir et al., 2011; Wang et al., 2012;
Blaustein et al., 2013; Matsuda-Lennikov et al., 2014; Arias et al.,
2015).
Undoubtedly, the information contained in the repertoire
of Akt PTMs, through what we call the still undeciphered
“Akt molecular code,” might contribute to relocalize Akt to a
particular subcellular compartment, target a specific pool of
substrates and trigger a specific response. Here, we studied
whether Akt is modified by S-palmitoylation, a reversible
thioester linkage of palmitate to cysteine residues catalyzed
by internal membrane-bound palmitoyl acyltransferases (PATs)
(Salaun et al., 2010; Martin et al., 2012). S-palmitoylation is
common in several proteins localized to the ER, lysosomes and
the PM, including some upstream and downstream signaling
components of the Akt pathway, such as Ras (Magee et al.,
1987) and eNOS (Haynes et al., 2000). hAkt1 has a predicted
S-palmitoylation site at C344, which is also present in hAkt2
and 3 and is conserved in mouse, rat, C. elegans and even
in the yeast S. cerevisiae closest homologue, Sch9. Here,
we show that Akt is indeed S-palmitoylated and that Akt1-
C344S mutation affects Akt phosphorylation and localization
patterns. Palmitoylation-deficient Akt increases the recruitment
of this kinase to cytoplasmic structures that colocalize with
lysosomes, particularly in response to autophagic stimuli.
Importantly, Akt1-C344S was unable to support adipocyte cell
differentiation in vitro.
MATERIALS AND METHODS
Cell Culture, Treatments, and Materials
Cell lines were grown and transfected according to the
manufacturer’s instructions using standard procedures (Blaustein
et al., 2009). HEK293T and HeLa Kyoto cells were grown
in high glucose (4.5 g/L glucose) Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) and penicillin/streptomycin (100 units/ml and 100 µg/ml
respectively, Thermo Fisher Scientific) in a 37◦C humidified
incubator containing 5% CO2. HEK293T medium was also
supplemented with 110 mg/L of sodium pyruvate. Cells were
plated (3 × 106 cells per 100 mm plates, 2 × 105 cells per well
for 6 well plates and 1 × 104 cells per well for 96 well glass-
bottom imaging plates) and grown for 24 h before transfection
and for another 24 h before treatment for the specified times.
All cell lines were transfected with FuGENE6 (Roche) or
Lipofectamine 2000 (Thermo Fisher Scientific) according to
the manufacturer’s instructions. Unless otherwise stated, all
experiments were performed in DMEM supplemented with
10% FBS. IGF-1 and 2-BP were obtained from Sigma-Aldrich.
Lysotracker Red (Thermo Fisher Scientific) was a kind gift from
Dr. Daniel Hochbaum.
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The inducible KO Akt1/2/3 preadipocyte cell line was
generated and differentiated as previously described (Cederquist
et al., 2017; Sanchez-Gurmaches et al., 2018). To generate this
cell line, primary brown adipocyte precursors (bAPC) cells
were isolated from P1 neonates, immortalized with pBabe-SV40
Large T antigen and were cultured in high glucose-DMEM
with 10% fetal calf serum (Hyclone) under 5% CO2. To induce
Akt1 and Akt2 deletion, Akt1fl/fl Akt2fl/fl (both alleles of Akt1
and Akt2 flanked by loxP sites) Akt3 KO cells containing the
estrogen regulated Cre UBC-Cre ERT2 construct were treated
on 2 consecutive days with 1 mM 4-hydroxy tamoxifen and
on the 3rd day the media was changed to regular media
to allow protein turnover. KO Akt1/2/3 pre-adipocytes were
infected with pBABE-pura-HA retroviruses into which WT
Akt1, Akt1-E17K or Akt1-C344S coding sequences were cloned.
For in vitro differentiation, pre-adipocytes cells were seeded at
4 × 104 cells/ml and allowed to reach confluence over 3 days
in medium containing 20 nM insulin, 1nM T3 (differentiation
medium). On day 4, cells were induced to differentiate with
20 nM insulin, 1nM T3, 0.125 mM indomethacin, 2 µg/mL
dexamethasone and 0.5 mM 3-isobutyl-1-methylxanthine. Two
days later the induction medium was replaced with fresh
differentiation medium and changed every two days until day 10.
Plasmids
pCMV6-HA-Akt1/2 and mutants derived from them have been
previously described (Ramaswamy et al., 1999; Yang et al.,
2009). Wild type Akt1/2 and mutants were subcloned into
pEYFP-N1, pECFP-N1 and pECFP-C1 (Clontech) as well as in
pBABE-puro-HA (for infection of Adipocytes) by PCR using
appropriated primers as already described (Blaustein et al.,
2013). C344S mutagenesis was performed by PCR. TGN38-
FRB-CFP and PDK1-GFP were a kind gift from Dr. V. Laketa.
pCS-memb-mCherry was a kind gift from Pablo Mammi and
Anabella Srebrow.
ABE Assay
HEK293T cells in 100-mm plates were transfected with either
WT or mutant versions of pCMV6-HA-Akt1/2 and pAkt1-YFP.
After 48 h, 90% confluent cells were washed with PBS and
lysed at 4◦C in 2 mL lysis buffer (50 mM Tris-HCl pH 7.4,
150 mM NaCl and 5 mM EDTA containing EDTA-free protease
inhibitor (Roche)). Two plates from each construct were pooled
(2 mg total protein/4 ml lysis buffer) and subjected to ABE assay
as previously described (Wan et al., 2007), with the following
modification: the cell lysate containing 10 mM NEM was
sonicated 15 s on/off for 10 periods and then the concentration
of NEM was adjusted to 2 mM for overnight treatment. The
rest of the procedure was performed as described by Wang and
coworkers (Wan et al., 2007). Briefly, after overnight treatment
to block free thiol groups, NEM was removed by sequential
chloroform-methanol precipitation. Half of each sample was then
treated with hydroxylamine and biotin-HPDP to exchange thiol-
bound fatty acids for biotin. Finally, proteins were precipitated
to remove free biotin. An aliquot (20% of this sample) was taken
after the biotinylation step to be used as the input (I) for each
sample. The remainder of the samples (PD) were pulled down
using NeutrAvidin-agarose resin (Thermo Scientific), and then
eluted with 5 mM DTT. The total amount of each fraction,
corresponding to eluates and inputs (80 and 20%, respectively)
was run in parallel in a 10% SDS-PAGE for subsequent transfer
onto a PVDF membrane, immunoblotted and quantified using
ImageJ to obtain a PD/I value. An important control omits the
hydroxylamine treatment step in the other half of each sample,
to reveal either inappropriate biotinylation or non-specific
streptavidin–agarose binding. These minus- hydroxylamine (-
HA) sample proteins are also non-specifically purified into the
experimental +HA sample and thus represent a source of false-
positive signal in the assay. Thus, the fraction of S-palmitoylated
Akt in each sample was obtained by subtracting non-specific pull
down (PD/I) (-HA) from specific PD/I (+HA) values.
3H-Palmitate Metabolic Labeling
For 3H-palmitate metabolic labeling, HeLa Kyoto cells were
starved for 1 h in minimal media and then incubated for 2 h in
minimal media supplemented with 200 µCi/mL 3H-palmitic acid
[9,10-3H(N)] (American Radiolabeled Chemicals ART 0129).
Cells were then lysed and lysates were immunoprecipitated with
antibodies against HA tag. After immunoprecipitation, proteins
were eluted, and samples were divided for Western blotting (one
fourth) and gel fixation (three fourths). Gels were exposed to
fixing solution (25% isopropanol and 10% acetic acid in H2O),
followed by a 30 min incubation with signal enhancer Amplify
NAMP100 (Amersham) and gel drying. Dried gels were exposed
to Hyperfilm MP (Amersham) film for 10-day to 6 week. In
some cases, 1 M hydroxylamine (pH 7.4) was added and samples
were incubated at room temperature for 5 min before loading
on SDS/PAGE. Western blots were done in parallel to show the
efficiency of the immunoprecipitation.
Western Blot Analysis
Protein extract preparation and western blot analysis were
performed as previously described (Blaustein et al., 2009).
Primary antibodies were all from Cell Signaling: Akt (#9272),
phospho-Akt (T308, #4056, S473, #4060 and T450, #9267),
GSK-3β (#9315) and phospho-GSK-3β (S9, #9336), except for
HA (MMS-101R, Covance) and GFP (11814460001, Roche).
Fluorescence from secondary antibodies IRDye 680RD and
IRDye 800RD (LI-COR Biosciences) was captured using an
Odyssey Imaging System (LI-COR Biosciences). To quantify
the bands obtained we used an Image Studio Lite (LI-COR
Biosciences) based analysis.
Molecular Dynamics Simulations
A complete protein structural determination for Akt1 is still not
available. MD simulations for wild type Akt1, the S-palmitoylated
form in C344 and the phosphorylated form in T308 (pT308)
were performed using as initial model the Homo sapiens structure
(PDBID: 4ekk) (Lin et al., 2012) where only the kinase and
regulatory domains, i.e., residues from 144 to 477 were included
as in previous studies (Lu et al., 2015; Mou et al., 2017). The
apo form was generated ruling out the phosphoaminophosphonic
acid-adenylate ester and the Mn2+ cation from the active site.
C344 was modeled in the thiolate form as it is required for
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S-palmitoylation. The Amber ff14SB force field was used for
protein residues (including pT308) (Maier et al., 2015), the
palmitoyl group parameters were extracted from the GAFFlipid
force field (Dickson et al., 2012) and the C344-palmitoyl
thioester bond was constructed. The systems were placed into
a truncated octahedral box of TIP3P water and after a standard
minimization and equilibration protocol, 200 ns long production
molecular dynamics (MD) were performed as described (Hugo
et al., 2017) using the Amber package (Case et al., 2005).
Trajectories visualization and drawings were performed with the
Visual Molecular Dynamics (VMD) program (Humphrey et al.,
1996). Eigenvector centrality measurements were performed as
described (Negre et al., 2018). Eigenvector centrality considers
the number of connections of a given node and its relevance
in terms of information flow. It is defined as the weighted
sum of the centralities of all nodes that are connected to
it by an edge and it is particularly relevant to characterize
allosteric mechanisms.
Cell Imaging and Image Analysis
For fluorescent reporter assays, cells were plated either into 96-
well (Matrical) or 8-well (Nunc R© Lab-Tek R© II) coverglass imaging
plates. After transfection and treatment, cells were fixed with 4%
paraformaldehyde in PBS for 5 min at room temperature, washed
twice with PBS, permeabilized for 5 min with 0.2% Triton X-
100 in PBS and stained with DAPI or Hoechst (Thermo Fisher
Scientific). Lysotracker Red (Thermo Fisher Scientific) was added
to live cells 1h before fixation. Wide-field images were captured
on an Olympus IX-81 fluorescence microscope equipped with a
63X PlanApo oil immersion objective (N.A. = 1.4), a motorized
XYZ stage and a Coolsnap HQ2 CCD camera (Photometrix,
Tucson AZ). Acquisition was carried out with MetaMorph
7.5 software (Universal Imaging Corporation, Downingtown,
PA). MetaMorph was also used to control the built-in
motorized XYZ-motor and cube changer. Image processing
and analysis were performed using the open source softwares
ImageJ and CellProfiler. Cell segmentation was performed
with the open source software CellProfiler. First, background
subtraction and illumination heterogeneities corrections were
performed with the module “Apply threshold” to nuclei,
Akt, and Golgi images. Nuclei segmentation was performed
with the module “IdentifyPrimaryObjects” on DAPI/Hoechst
images while entire cells were segmented with the module
“IdentifySecondaryObjects” on the Akt images. Clumped objects
were distinguished by shape and cell lines between them
were drawn taking into account their shape as well. In all
cases we used global strategies and the Otsu method. After
measuring cell shape and fluorescence intensity, cells that were
too big, too small or did not express enough fluorescent
reporter were filtered and discarded. Golgi was segmented
using the enhance operation on “EnhanceOrSuppressFeatures”
module and selecting the feature type as “Speckles.” Then
“IdentifyPrimaryObjects” module was applied with strategies per
object and “RobustBackground” thresholding method. Clumped
objects were distinguished by intensity and cell lines between
them were drawn taking into account their intensity as well.
Then, the individual Golgi structures segmented were grouped
with the “RelateObjects” module. At the end, the cytoplasm object
was segmented using the “IdentifyTertiaryObjects” module by
subtracting the organelles objects corresponding to each cell.
For each object, we measured mean and total signal as well as
the area. Akt recruitment to each subcellular compartment was
measured as its mean intensity in the region. Each value was
normalized by the corresponding Akt cytosolic mean intensity
to correct for Akt expression levels. Data analysis and graphs
were fulfilled using RStudio and Matlab. At least 100 cells
were analyzed for each experiment. Colocalization of Akt-
C344S and lysosomes (or DNA as a control) was determined
calculating the Pearson’s correlation coefficient with the ImageJ
Coloc2 plugin. The mean +/- standard deviation from different
regions was computed. Akt recruitment to PM was measured
as the average ratio between PM (maximum) and cytosolic
(minimum) Akt signals in Region of Interest (ROI) from different
cells, using ImageJ.
Gene Expression Analysis
RNA isolation, retro-transcription and quantitative RT-PCR
were performed using standard procedures. Total RNA was
isolated from cells using Qiazol reagent (Invitrogen) and RNeasy
kit (Invitrogen). Equal amounts of RNA (2 µg) were retro-
transcribed to cDNA using a high-capacity cDNA reverse
transcription kit (#4368813, Applied Biosystems). Quantitative
RT-PCR was performed in 10 µL reactions using a StepOnePlus
real-time PCR machine from Applied Biosystems using 2X SYBR
Green PCR master mix (#B21203, Biomake.com) according to
manufacturer instructions. Standard and melting curves were run
in every plate for every gene to ensure efficiency and specificity
of the reaction. Tbp expression was used as a housekeeping
gene in all RT-PCR experiments. Primer information is listed in
the table below.
Primer sequences for quantitative RT-PCR analysis:






Oil Red O (ORO Staining)
Cells were fixed with 4% paraformaldehyde, washed with distilled
water and treated with 100% propylene glycol twice for 5 min
followed by a 15 min incubation with oil red O solution. Then
cells were washed with 85% propylene glycol for 3 min and rinsed
twice in distilled water.
Statistical Analysis
Comparisons were performed using one-tailed Student’s t test
and one-way analysis of variance (ANOVA), combined with
Tukey’s test. Except otherwise stated, data are represented as
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It is usually assumed that inactive, cytosol residing Akt is
recruited to the PM in response to extracellular stimuli resulting
in its phosphorylation and detachment. This fully activated
version of Akt orchestrates the regulation of a great variety
of targets and functions in the cytosol and the nucleus in a
concerted fashion (Figure 1A). However, recent data shows
that Akt activation and relocalization mechanisms, including its
recruitment to internal membranes, are more complex and, so
far, not fully understood (Risso et al., 2015; Guo et al., 2016;
Manning and Toker, 2017; Liu et al., 2018). Some proteins linked
to the Akt signaling pathway, such as Ras (Magee et al., 1987) and
eNOS (Haynes et al., 2000), shuttle between ER, Golgi, lysosomes
and PM using S-palmitoylation at Golgi and/or ER membranes
as a reversible anchor. Because Akt itself localizes to internal
membranes, we speculated that the pool of Akt proteins residing
at these membranes could be also regulated by this PTM.
To test the hypothesis that Akt is S-palmitoylated, we first
used the CSS-Palm prediction tool (Ren et al., 2008). Indeed,
CSS-Palm indicated that hAkt1 has an S-palmitoylation motif
centered on cysteine C344 (C345 and C341 in hAkt2 and 3,
respectively). Notably, this motif is conserved in mice, rats,
worms and in the closest Akt homolog present in S. cerevisiae,
Sch9 (Supplementary Table 1). Interestingly, the described SNPs
around C344 in human Akt1 (such as variant rs56289559) are
either synonymic or maintain the S-palmitoylation consensus
according to the Variation Viewer (NCBI) and the Genome
Aggregation Database (gnomAD) (Karczewski et al., 2020),
suggesting strong selection against losing this consensus.
Next, we assessed if Akt was S-palmitoylated using an
acyl-biotin exchange (ABE) assay (Wan et al., 2007). In this
assay (Figure 1B), the palmitoyl group is exchanged by a
sulfhydryl-reactive biotin derivative (biotinamido hexyl-pyridyl
dithio propionamide, Biotin-HPDP), and then streptavidin is
used to pull-down the labeled proteins, which are finally detected,
for example, by western blot. In this way, we detected that Akt1
and Akt2 were indeed S-palmitoylated in extracts of unstimulated
HEK293T cells transfected with tagged forms of these kinases
(Figure 1C). Palmitoylation was reduced to background levels
when we transfected the mutant Akt1-C344S, indicating that
cysteine 344 was the target of this PTM (Figure 1C). To verify
bona-fide Akt palmitoylation, we performed in vivo metabolic
labeling of a different cell line, HeLa Kyoto, using 3H-palmitate,
followed by immunoprecipitation of Akt1. After separation in an
SDS-PAGE gel, a radioactive band corresponding to Akt could
be clearly detected. As with the ABE assay, this band was absent
when using cells transfected with Akt1-C344S (Figure 1D).
The above results indicated the presence of a fraction
of palmitoylated Akt in basal, unstimulated HEK293T and
HeLa Kyoto cells. Inactive Akt has been suggested to be a
cytosolic protein. The highly hydrophobic nature of the palmitate
group made the scenario of a soluble cytosolic palmitoylated
Akt unlikely. One possibility is that the palmitoylated Akt
molecules we detected were attached to internal cell membranes
in unstimulated cells. The fact that several PATs are Golgi-
membrane enzymes (Salaun et al., 2010; Martin et al., 2012)
caused us to examine if Akt could be found in this location.
Indeed, we observed a significant colocalization of Akt-YFP with
a Golgi marker in a large proportion of unstimulated HeLa
Kyoto cells (Figures 1E,F), suggesting that a subpopulation
of Akt molecules might be palmitoylated in these membranes
in basal cell-culture conditions. Moreover, we found that
PDK1-GFP, the Akt activating kinase, also colocalized with
the Golgi marker (Figure 1G), placing it in the appropriate
location to phosphorylate Akt in this subcellular structure. All
together, these results are consistent with the possibility that
in unstimulated cells the Golgi subpopulation of Akt molecules
could be palmitoylated by resident PATs, and eventually,
activated by PDK1.
We next wondered how S-palmitoylation of Akt might affect
its 3D structure. To answer this, we performed molecular
dynamics simulations of Akt1 with different PTMs (Figure 2A).
In our simulations, S-palmitoylation at C344 (Figure 2B, red
line) generated changes in conformational freedom with respect
to the unpalmitoylated original form (black line), but only
in a few areas of the simulated kinase. Notably, a strongly
affected region (large difference between black and red) was
the area near T308, the key threonine whose phosphorylation
by PDK1 is indispensable for Akt1 activation (Figures 2B,C).
Reciprocally, simulation of T308 phosphorylation (Figure 2B,
blue line) led to a change in the conformational freedom of the
area near C344. These results suggested that these two regions
(the neighborhood of C344 and T308) are structurally linked.
In support of this notion, eigenvector centrality measurement of
mutual information, a recently developed strategy to characterize
the range of correlations that underlie allosteric processes (Negre
et al., 2018), also suggested the presence of a structural allosteric
effect connecting changes at C344 and T308 (Figure 2D).
Taken together, our simulation data raised the possibility
that Akt S-palmitoylation might not only regulate its membrane
association but also its activation state. This is consistent with
some reports that indicate that sometimes S-palmitoylation
influences other PTMs, including phosphorylation, therefore
affecting protein activity (Salaun et al., 2010).
Akt1-C344 Mutant Displays Altered
Phosphorylation Patterns
Our molecular dynamics simulations suggested that Akt
S-palmitoylation at internal membranes could be influencing
Akt activation and particularly PDK1-dependent Akt
phosphorylation at T308. Interestingly, we found that
phosphorylation at T308 was decreased 3-fold in the Akt1-C344S
mutant (Figures 3A,B), suggesting that the non-palmitoylated
Akt1 could be less active. In addition, phosphorylation at
T450 was also reduced in Akt1-C344S relative to WT Akt1
(Figures 3A,C), while no significant differences were observed
regarding phosphorylation of S473 (Figures 3A,D).
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FIGURE 1 | Akt is S-palmitoylated. (A) A traditional perspective of the Akt activation cycle assumes that PI3K, which converts PM associated PIP2 to PIP3 in
response to Growth Factors (GF) and other stimuli, leads to PIP3- mediated recruitment of cytosolic Akt to PM. The conformational change elicited by Akt PH
domain binding to PIP3 allows phosphorylation of Akt by PDK1 and mTORC2. As a result, activated Akt concertedly regulates a great variety of targets and
functions in the cytosol and the nucleus. (B) Scheme of the ABE assay. It consists of three steps: Blocking free thiols with N-ethylmaleimide (NEM), conversion of
thioester-linked palmitoyl moieties into thiols with a hydroxylamine (HA) treatment and biotinylation with biotin–HPDP. (C) Bar plots show the fraction of palmitoylated
HA-Akt relative to HA-Akt1 (mean +/- SEM) in transiently transfected in HEK293T cells (similar results were obtained using HA or YFP tags), as determined using the
ABE assay. An aliquot of each sample was taken before Pull-down (PD) and was used to measure the input (I). In HA- samples, the hydroxylamine treatment step
was omitted. The fraction of palmitoylated Akt in each sample was obtained by subtracting non-specific pull down (PD/I) (-HA) from specific PD/I (+HA) values. The
values were expressed as relative to WT Akt1 palmitoylation. *p < 0.05 compared to WT Akt1 (Student’s t-test). (D) HeLa Kyoto cells were either transfected with
plasmids coding for WT HA-Akt1 or HA-Akt1-C344S and labeled with 3H-Palmitate, followed by immunoprecipitation of HA-Akt1. Radioactive signal and western
blots are shown. 3H-palmitate to HA-Akt1 (3H/HA) ratios were plotted as relative to WT Akt1 palmitoylation. *p < 0.05 compared to WT Akt1 (Student’s t-test).
(E) HeLa Kyoto cells were co-transfected with a plasmid coding for Akt1-YFP (green) and a plasmid coding for a Golgi fluorescent marker (TGN38-FRB-CFP,
magenta). DAPI was used to reveal cell nuclei (blue); scale bar, 5 µm. (F) Box plot shows Akt recruitment to Golgi (and nucleus, as a reference) in HeLa Kyoto cells
(n > 100). Akt recruitment to each subcellular compartment was measured as its mean intensity in the region. Each value was normalized by the corresponding Akt
cytosolic mean intensity to correct for Akt expression levels. Median appears in red, the first and third quartiles in blue and minimum/maximum as error bars.
(G) HeLa Kyoto cells were co-transfected with a plasmid coding for PDK1-GFP (green) and a plasmid coding for a trans-Golgi fluorescent marker (TGN38-FRB-CFP,
magenta). DAPI was used to reveal cell nuclei (blue); scale bar, 10 µm.
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FIGURE 2 | Effect of S-palmitoylation on Akt 3D structure. (A) Alignment of unmodified (gray) and S-palmitoylated (red) representative structures of apo-Akt1 model.
C344, T308 and palmitoyl group are depicted in balls and cylinders for the S-palmitoylated protein. Protein backbone connecting T308 and C344 is highlighted in
black. (B) Root mean square fluctuation (rmsf, Å) per residue for unmodified Akt1 (black), palmitoylated-C344 Akt1 (red) or phospho-T308 Akt1 (blue). Yellow boxes
highlight T308 and C344 areas. (C) Comparison of solvent accessible surface area (SASA, Å2) of T308 obtained from unmodified (black) and S-palmitoylated (red)
MD simulations. *p < 0.01 compared to C344 thiolate (Student’s t-test). (D) Eigenvector centrality measurement of mutual information for characterization of
T308-C344 structural connection.
Given that Akt1-C344S lacks the anchoring function provided
by the palmitoyl group, we also wondered if it has a diminished
capacity to be recruited to the PM, as it has been shown for
other proteins (Sato et al., 2009). To test that, we transfected
cells with either WT Akt1-YFP or Akt1-C344S-YFP, stimulated
them with IGF-1 and measured Akt1 translocation to the PM
(Figures 3E,G). We found no significant differences in PM
recruitment between WT Akt1 and the C344S mutant. To
complement this approach, we evaluated the ability of C344S
mutation to affect PM recruitment of the oncogenic Akt1-E17K
mutant (Figure 3F). The Akt-E17K mutant has been identified
in human cancer patients and exhibits clear PM recruitment
even in the absence of stimulus (Carpten et al., 2007). This is
because the E17K mutation is in the PH domain and it has
been shown to change the phospholipid specificity increasing
binding to PIP2 instead of PIP3 (Landgraf et al., 2008). Again,
we found that introduction of the C344S mutation did not alter
PM recruitment (Figure 3G). These two experiments suggest that
PM recruitment might be palmitoylation independent. However,
more detailed studies are needed to rule out a role of this PTM in
PM localization.
Palmitoylation-Deficient Akt Increases
Its Recruitment to Cytoplasmic
Structures That Colocalize With
Lysosomes
A small but significant fraction of cells (between 5 and
10%) transfected with the S-palmitoylation mutant Akt1-C344S-
YFP accumulated fluorescence in the form of cytoplasmic
puncta (Figure 4A). This was not observed in WT Ak1-YFP
overexpressing cells (Figures 3E, 4B), suggesting that this PTM
might affect Akt1 recruitment to subcellular compartments. For
some proteins, such as Hck, depalmitoylation leads to their
accumulation in lysosomes (Sato et al., 2009). Thus, we wondered
if the Akt1-C344S puncta represented localization to these
organelles. Indeed, Akt1 puncta colocalized with LysoTracker
red, a live staining dye that accumulates in low pH environments
such as the lumen of lysosomes (Figure 4B and Supplementary
Figure 1). Importantly, cells transfected with WT Akt1-YFP and
treated with the palmitoylation inhibitor 2-bromopalmitate (2-
BP), also exhibited this punctuated pattern, in around 30% of
the cells (Figure 4C), arguing that lysosomal localization was
due to the missing PTM and not merely due to a structural
effect of the mutation of a cysteine 344 to serine, unrelated
to the lipid addition. These results suggested that Akt1 might
play a cellular function in lysosomes and that depalmitoylation
facilitates, or be required for, lysosome targeting. Surprisingly,
when we co-transfected WT Akt1-CFP and Akt1-C344S-YFP,
we observed WT Akt in puncta, where Akt1-C344S was also
present (Figure 4D), suggesting that recruitment of WT Akt1
to lysosomes could be induced by Akt1-C344S itself. Given
that only a small percentage of cells show this localization, our
data also suggests that other factors are necessary for Akt1 to
reach this organelle.
To find a potential role of Akt1 in lysosomes, we used
the STRING database (Szklarczyk et al., 2017) to analyze the
list of already known Akt substrates (Moritz et al., 2010;
Hornbeck et al., 2015). We then performed a gene ontology
(GO) analysis of the biological processes linked to Akt targets
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FIGURE 3 | C344S mutation affects Akt1 phosphorylation. (A–D) HEK293T cells were transfected with WT or C344S Akt1-YFP. Protein extracts were analyzed by
western blot using the indicated antibodies (duplicates are shown). Data in the plots corresponds to the ratio (mean +/- SEM) of phosphorylated to total YFP-tagged
Akt. *p < 0.05 compared to WT in each case (Student’s t-test). (E–G) HeLa Kyoto cells were transfected with WT Akt1-YFP or Akt1-C344S-YFP (E), or
Akt1-E17K-YFP or Akt1-E17K-C344S-YFP (F) (yellow). Cells were serum-starved and treated with 100 ng/mL IGF-1 for 5 min or left untreated. DAPI was used to
reveal cell nuclei (blue); scale bar, 5 µm. Akt recruitment to PM (G) was measured as the average ratio between PM (maximum) and cytosolic (minimum) Akt signals
in Region of Interest (ROI) from different cells, using ImageJ. No significant differences were found between WT and C344S in each case (Student’s t-test).
associated to lysosomes and other connected organelles, and
found an enrichment in GO terms related to the response to
reactive oxygen species, as well as to autophagy and apoptosis
(Supplementary Figure 2). Consistently, we found a total of
24 already known Akt substrates that are associated with the
regulation of autophagy (Supplementary Figure 3). This analysis
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FIGURE 4 | A link between Akt S-palmitoylation, lysosome recruitment and the response to oxidative stress. (A) An example of untreated cells displaying
Akt1-C344S-YFP in cytoplasmic puncta; scale bar, 5 µm. (B) HeLa Kyoto cells were transfected with a plasmid coding for Akt1-C344S-YFP (green) and live stained
with Lysotracker Red to observe lysosomes (magenta). DAPI was used to reveal cell nuclei (blue); scale bar, 5 µm. The Pearson’s correlation coefficient was
calculated in different ROI (marked with arrows) obtaining an average of 0.71 +/– 0.12 between Akt1-C344S-YFP and Lysotracker Red (as a control, a correlation
coefficient of 0.17 +/– 0.28 was obtained when comparing Akt1-C344S-YFP and DNA). (C) HeLa Kyoto cells were co-transfected with plasmids coding for a PM
fluorescent marker (pCS-memb-mCherry, red) and WT Akt1-YFP (yellow). 48 h later, cells were treated with 100 µM of the palmitoylation inhibitor 2-BP or DMSO
(vehicle) for 1 h and fixed. A significant increase in the proportion of cells displaying WT Ak1-YFP in puncta (one at least) was found when we treated them with 2-BP
(from 1% in control to 30% in cells treated with 2-BP, p < 0.05 according to Student’s t-test). PM localization of pCS-memb-mCherry depends on the palmitoylable
N-terminal sequence of Lyn kinase and therefore it was used as a positive control of the effect of 2-BP. DAPI was used to reveal cell nuclei (blue); scale bar, 5 µm.
(D) HeLa Kyoto cells were transfected with a plasmid coding for Akt1-C344S-YFP (magenta) and/or a plasmid coding for WT Akt1-CFP (green). After 48 h, cells
were fixed. Left: normal WT Akt1-CFP localization. Right: Localization of WT Akt1-CFP in cells with Akt1-C344S-YFP puncta. DAPI was used to reveal cell nuclei
(blue); scale bar, 5 µm. (E) HeLa Kyoto cells were transfected with a plasmid coding for either WT or Akt1-C344S-YFP. Forty-eight hours later, cells were incubated
for 3 h in the presence or absence of 10 mM hydrogen peroxide, fixed, and cells were scored as having or not YFP signal in puncta. Data in the plots corresponds to
the fraction of cells containing YFP in puncta (mean +/- SEM). Letters indicate significant differences (ANOVA). a. p < 0.05 compared to untreated cells expressing
the same version of Akt. b. p < 0.05 compared to WT Akt1-YFP cells under the same treatment. (F) HeLa Kyoto cells were transfected with a plasmid coding for
either WT or Akt1-C344S-YFP. Live cells were imaged every 20 min to deliberately induce photo-damage. At every time point, we performed a Z Series with 3 z
steps of 1 µm for 3 different wavelengths (RFP, exposure: 0.2 s; YFP, exposure: 0.5 s; CFP, exposure: 0.1 s) and cells were scored as having or not YFP signal in
puncta. Data in the plots corresponds to the fraction of cells containing YFP in puncta (mean +/- SEM). Letters indicate significant differences (Student’s t-test): a.
p < 0.05 compared to the same cells at t = 0’. b. p < 0.05 compared to WT Akt1-YFP cells at t = 80’.
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is in good agreement with recent reports demonstrating that
Akt regulates lysosome-dependent autophagy (Wang et al., 2012;
Matsuda-Lennikov et al., 2014; Arias et al., 2015).
The above analysis suggested that an autophagy-inducing
input, such as oxidative stress, might lead to Akt relocalization
to lysosomes. To test that possibility, we transfected HeLa Kyoto
cells with WT Akt1-YFP and stimulated cells with two well-
known inducers of oxidative stress: hydrogen peroxide (H2O2)
(Chen et al., 2008) and photodamage (Kessel and Arroyo, 2007).
Notably, both stimuli caused a significant proportion of cells
with WT Akt1 to form cytoplasmic puncta (Figures 4E,F and
Supplementary Figure 1B). The effect was much larger when
we repeated this experiment using the palmitoylation deficient
Akt1, resulting in approximately 50% and 75% of cells to show a
punctuated pattern that colocalized with lysosomes in response
to H2O2 and photodamage, respectively (Figures 4E,F and
Supplementary Figure 1C). These results support the notion
that depalmitoylated Akt1 has a larger propensity to be recruited
to lysosomes in response to inducers of oxidative stress and
autophagy, and suggest that regulated depalmitoylation might be
a normal step required for lysosome targeting.
Overall, these results indicated that impairing Akt
S-palmitoylation does not prevent Akt translocation to the
PM but increases Akt recruitment to lysosomes, a process
stimulated by inducers of oxidative stress and autophagy.
Akt Recruitment to Lysosomes Is
Accompanied by Golgi Disassembly and
Nuclear Condensation
Interestingly, virtually all the cells displaying Akt in lysosomes
also exhibited a change in Golgi structure from the typical
perinuclear network to dispersed vesicles (Figure 5A). As
expected, these vesicles do not colocalize with Akt puncta
(Figure 5B). The change in Golgi structure is reminiscent of
that observed during cell death (Foiani and Bartek, 2014).
Photodamage induced by live-imaging microscopy revealed
that Akt localization to lysosomes appeared during a process
which also included nuclear condensation and cell blebbing
(Figure 5C and Supplementary Movies 1 and 2). Consistently,
unstimulated cells displaying Akt1-C344S in lysosomes presented
reduced nuclear area compared with normal cells expressing WT
Akt1 (Figure 5D).
Palmitoylation-Deficient Akt Blocks Cell
Differentiation
Autophagy is highly active during differentiation (Mizushima
and Levine, 2010), particularly in the adipose tissue (Singh
et al., 2009). Therefore, we wondered whether cells expressing
the S-palmitoylation mutant Akt1-C344S have alterations in this
Akt-dependent differentiation process (Cederquist et al., 2017).
To assess this, we used an in vitro Akt-dependent adipogenic
differentiation model, in which preadipocytes are induced to
differentiate using a standard 10-day protocol. To test the role
of Akt, we used a brown preadipocyte cell line in which the
triple knock-out (KO) of Akt1/2/3 may be induced, allowing us to
express our WT or C344S mutants as the sole source of Akt (see
section “Materials and Methods”). As with HeLa Kyoto cells, we
observed that Akt1-C344S displays significantly diminished T308
phosphorylation in these triple Akt KO cells before initiating the
differentiation protocol (Figure 6A). Remarkably, we found that
Akt1-C344S was functionally defective, as determined by a clear
reduction in the phosphorylation levels of GSK3β, a canonical
Akt substrate (Figure 6A). Finally, we found that neither
Akt1-C344S nor Akt1-E17K, which stimulates cell proliferation,
could replace WT Akt1 in its ability to support preadipocyte
differentiation, as determined by expression analysis of key genes
related to de novo lipogenesis and adipocyte differentiation as
well as the ability to accumulate lipids -Oil Red O (ORO)
staining- (Figures 6B,C).
DISCUSSION
A growing body of evidence supports the idea that recruitment
of components of the Akt pathway to particular subcellular
compartments may be central to determine the specific set of
Akt substrates targeted and therefore the particular group of
Akt functions activated (Menon et al., 2014; Marat et al., 2017).
During the last few years, novel regulatory mechanisms of Akt
activity were described, such as phosphorylations (Liu et al.,
2014), ubiquitination (Yang et al., 2009), proline hydroxylation
(Guo et al., 2016) and methylation (Yoshioka et al., 2016; Guo
et al., 2019; Wang et al., 2019). Quite some work still needs to be
done to understand the way in which the activity and localization
patterns of this kinase is controlled. For example, it was recently
shown that production of PI34P2 may account for isoform- and
site- specific activation of Akt (Liu et al., 2018).
Here, we present evidence for a new Akt PTM:
S-palmitoylation. This reversible modification has been shown
to increase protein surface hydrophobicity and membrane
affinity, modulating protein sorting and stability (Linder
and Deschenes, 2007), phosphorylation and activity (Salaun
et al., 2010), as well as numerous cellular processes, including
apoptosis (Chakrabandhu et al., 2007). Interestingly, not all
the algorithms predicted an Akt S-palmitoylation consensus as
CSS-Palm. While SwissPalm (Blanc et al., 2015) predicts the
same consensus as CSS-Palm, SeqPalm (Li et al., 2015) estimates
a score for C344 palmitoylation which is not high enough to
be considered as putative consensus. Our experimental data,
however, is consistent with CSS-Palm and SwissPalm predictions,
implying that prediction accuracy may vary depending on the
protein analyzed. The Akt S-palmitoylation consensus seems
to be highly conserved across evolution, and thus we are
confident that this PTM plays an important role in other
species. Our findings showing that Akt is palmitoylated at
C344 in mammalian cells could be of paramount importance
to understand Akt partitioning throughout internal cell
membranes. S-palmitoylation was reported for some signaling
molecules of the Akt pathway, such as Ras (Magee et al., 1987)
and eNOS (Haynes et al., 2000). In this line of evidence, it
was recently described that a novel Akt phosphatase, Small
CTD Phosphatase 1 (SCP1) depends on palmitoylation at
Golgi membranes in order to shuttle to the PM, where it
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FIGURE 5 | Akt recruitment to lysosomes is accompanied by Golgi disassembly and nuclear condensation. (A) HeLa Kyoto cells were co-transfected with a
trans-Golgi fluorescent marker (TGN38-FRB-CFP, magenta) and either WT-YFP or Akt1-C344S-YFP (yellow). Dissociation of the typical Golgi structure into vesicles
can be seen in cells displaying Akt puncta. DAPI was used to reveal cell nuclei (blue); scale bar, 5 µm. (B) Akt puncta (green) do not colocalize with Golgi (magenta).
(C) Puncta formation in Akt1-C344S cells is accompanied by cell blebbing, nuclear condensation and fluorescence loss (yellow numbers indicate the percentage of
yellow fluorescence remaining in the cell at each time point, compared to t = 0). HeLa Kyoto cells constitutively expressing H2B-mCherry (blue) were transfected with
a plasmid coding for Akt1-C344S-YFP (yellow). Live cells were imaged every 20 min. Every time point (minutes, white numbers), we acquired a z-stack with 3
z-steps of 1 µm in 2 different wavelengths (RFP, exposure: 0.2 s and YFP, exposure: 0.5 s). Bar, 10 µm. (D) Akt1-C344S cells displaying Akt puncta show reduced
nuclear area compared to WT Akt1-YFP expressing cells (p < 0.01 according to a Student’s t-test).
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FIGURE 6 | Akt1-C344S cannot support pre-adipocyte differentiation. (A) UBC-Cre Akt1/2/3 KO brown pre-adipocytes were infected with pBABE-pura-HA
retroviruses into which WT Akt1, Akt1-E17K or Akt1-C344S coding sequences were cloned. Protein extracts were analyzed by western blot using the indicated
antibodies. Numbers below correspond to the ratios of phospho-T308 Akt (pAkt) to total HA-tagged Akt, phospho-GSK3β (pGSK3β) to total GSK3β and pGSK3β to
total HA-tagged Akt. Differences in Akt T308 and GSK3β phosphorylation between cells expressing WT HA-Akt1 and HA-Akt1-C344S were significant (ANOVA).
(B) RT-qPCR analysis shows the expression of genes normally induced during de novo lipogenesis and adipocyte differentiation in cells expressing different Akt
versions. Tbp expression was used as a housekeeping gene in all RT-PCR experiments. *p < 0.05 compared to WT Akt1 (ANOVA). (C) Oil Red O (ORO) staining
reveals lipid accumulation in cells expressing different Akt versions (scale bar, 30 µm). The numbers show the area percentage in red. Cells expressing each of the
Akt1 mutants display significant less amount of lipid accumulation compared to cells expressing WT Akt1 (ANOVA).
would inhibit Akt activity (Liao et al., 2017). Most probably,
Akt palmitoylation takes place after or during Akt binding
to internal membranes, a process increasingly studied in the
last few years (Siess and Leonard, 2019; Sugiyama et al., 2019;
Yudushkin, 2019). Our results revealing the presence of Akt
and PDK1 in Golgi membranes of unstimulated HeLa Kyoto
cells are compatible with basal Akt palmitoylation by PATs
residing on these membranes. Once palmitoylated, it is likely that
these modified Akt molecules shuttle between different internal
membranes as it has been shown for other palmitoylated proteins
(Sato et al., 2009). Unless associated to a lipid binding protein
(such as a G-protein GDP-dissociation inhibitor (GDI)) that
could isolate the palmitate, the presence of soluble palmitoylated
Akt molecules is unlikely (Olofsson, 1999). Further experiments
are needed to precisely understand where and how is Akt
palmitoylated as well as which is/are the PAT(s) responsible for
this PTM and which are the stimuli that regulate it.
Our results showed that a mutant Akt1 that cannot
undergo S-palmitoylation has reduced phosphorylation levels.
A straightforward explanation for this effect is that the
unpalmitoylated Akt1 fails to associate correctly with the
membrane where it is modified by PDK1. However, molecular
dynamics simulations of Akt1 with different PTMs suggested
that cysteine 344 and threonine 308 are structurally closely
connected, since modifications of C344 cause a clear change
in the behavior/solvent exposure of T308, and vice versa.
Thus, Akt S-palmitoylation might produce an allosteric effect
modifying the neighborhood of T308, in a way that could
conceivably affect the ability of PDK1 to act on this site. In
summary, S-palmitoylation might affect the exact positioning,
and thus the exposure, of this phosphorylation target amino
acid. Moreover, palmitoylation and phosphorylation might
combine synergistically to alter Akt1 function: one of the
functions attributed to T450 phosphorylation is to reduce Akt
ubiquitination, affecting Akt conformation and stability (Risso
et al., 2015). Consistently, S-palmitoylation has been shown to
modulate protein ubiquitination (Linder and Deschenes, 2007).
Since Akt can be ubiquitinated at K8, 14 and 284, these results
raise the possibility that S-palmitoylation plays a role not only
in regulating Akt activation status through phosphorylation but
also indirectly through Akt ubiquitination. Further experiments
will be necessary to address this statement.
Akt has been described as a Phafin2 and Beclin 1 kinase,
regulating lysosome-dependent autophagy (Wang et al., 2012;
Matsuda-Lennikov et al., 2014; Arias et al., 2015). Recently,
the existence of pools of AKT that are sensitive to lysosome
positioning have been demonstrated (Jia and Bonifacino,
2019). We found that the Akt1-C344S mutation induces
Akt relocalization to cytoplasmic puncta that correspond to
lysosomes, a process stimulated by oxidative stress and linked
to autophagy. The palmitoylation inhibitor 2-BP elicited the
same relocalization pattern in WT Akt1, confirming these results.
Moreover, blocking Akt1 S-palmitoylation impaired the ability of
preadipocytes to accumulate lipids and to differentiate, a process
also associated to cell autophagy (Singh et al., 2009; Mizushima
and Levine, 2010). This is particularly relevant, since the adipose
tissue largely depends on the existence of a proper balance
between lipid storage and utilization, a process basically mediated
by insulin signaling and the Akt pathway (Cederquist et al., 2017).
The observation that the oncogenic Akt1-E17K mutant, which
induces cell proliferation and survival, also impaired the ability of
preadipocytes to accumulate lipids and in general to differentiate
further supports the idea of a complex Akt molecular code in
which different PTMs could trigger higher or lower Akt activity
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depending on the molecular function, subcellular compartment
or biological process regulated by this kinase. Moreover, E17K
mutation elicits different phenotypes depending on the isoform
of Akt affected (Manning and Toker, 2017). Our conclusions
regarding the function of Akt S-palmitoylation are based on
experiments with a palmitoylation-deficient Akt mutant and the
use of 2-BP, a compound that blocks general palmitoylation.
While C344S mutation could affect the structure and function
of Akt independently of Akt S-palmitoylation, 2-BP, for its
part, could have non-specific effects by affecting palmitoylation
of other proteins in addition to Akt. However, the fact that
two different experimental strategies generate similar effects
suggests that the results are genuinely associated with the role
of Akt S-palmitoylation. Future experiments should complement
this approach by analyzing the phosphorylation and specific
subcellular localization of palmitoylated and non-palmitoylated
WT Akt. Further research should also address whether PIP3
binding play any role in the relocalization of unpalmitoylated
Akt, for example by studying the localization of a 1PH-Akt1-
C344S double mutant.
Understanding the interplay between the patterns of PTMs
and subcellular localization of a given signaling protein not
only represents a progress in the understanding of the
mechanisms governing the regulation of the studied protein,
but also a way to understand general mechanisms by which
cells integrate, translate and transduce molecular codes into
spatial information cues and vice versa. In the case of
Akt, a protein involved in tumor progression (Altomare and
Testa, 2005; Riggio et al., 2012) and in viral infections,
including coronavirus (Tsoi et al., 2014), fine-tuning of
these biological processes and functions can be essential for
cell decision-making mechanisms during disease onset and
progression. While we were able to observe Akt palmitoylation
in unstimulated cells, how stimulation affects Akt palmitoylation
remains an open question. Further experiments will be
needed in order to understand the detailed mechanisms that
govern Akt S-palmitoylation, localization and function and
which stimuli regulate this PTM. However, our results leave
us a step closer to deciphering the Akt molecular code.
Particularly, our data are compatible with a role of Akt
S-palmitoylation in phosphorylation, localization and function
of this kinase, influencing key processes like autophagy, cell
differentiation and cell death.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
AUTHOR CONTRIBUTIONS
MB and AC-L designed the research and wrote the manuscript.
MB performed most of the experiments. MB, EP, CMC, AV,
and AA performed microscopy and image analysis. MVM and
MMC performed ABE assays. LA and FGvdG designed and
performed 3H-palmitate labeling experiments. AZ performed
MD simulations. CMC and DAG designed and performed
adipocyte differentiation experiments. MB, CMC, AV, AA, LA,
and MVM performed western blot experiments. MV assisted in
cell culture experiments. All authors contributed to the article
and approved the submitted version.
FUNDING
This work was supported by grants from the Argentine Agency
of Research and Technology (ANPCyT- PICT 2011-0065 and
2016-0130 to MB, ANPCyT- PICT 2010-2248 and 2013-2210 to
AC-L, and ANPCyT- PICT2014-1917 to MMC), the Argentine
Council of Research and Technology (CONICET), the University
of Buenos Aires (UBACyT 20020130100793 and 20020170100653
to AC-L and MB), and the Argentine National Institute of Cancer
(INC 2018-2019 to MB).
ACKNOWLEDGMENTS
We thank J. Clemente, A. Bush, G. Vasen, P. Dunayevich,
A. Constantinou, A. Grande, V. Repetto, E. Altszyler, A. C.
Ventura, J. P. Di Bella, M. Suaya, G. Sánchez, M. García
Carrillo, M. Cotarelo, V. Buggiano, M. López Gringauz,
J. Piñero, L. Furlong, M. Reiss, and U. N. Morzan for
helpful discussions, suggestions and technical help. We
gratefully acknowledge support from the EMBL Advanced Light
Microscopy Core facility.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fcell.2021.
626404/full#supplementary-material
Supplementary Figure 1 | Akt1-C344S cytosolic puncta colocalize with
lysosomes. (A) HeLa Kyoto cells were transfected with a plasmid coding for
Akt1-C344S-YFP (green) and live stained with Lysotracker Red to observe
lysosomes (magenta); scale bar, 5 µm. 3D Surface Plots of specific cytosolic
areas are shown. (B) HeLa Kyoto cells were transfected with a plasmid coding for
Akt1-C344S-YFP. Oxidative stress was induced by photo-damage as in
Figure 4F (left) or by treatment with 10 mM hydrogen peroxide for 3 h as in
Figure 4E (right). Arrows indicate cells displaying Akt in puncta. Scale bar, 5 µm.
(C) HeLa Kyoto cells were transfected with a plasmid coding for WT Akt1-YFP.
Cytoplasmic Akt puncta in cells with 10 mM hydrogen peroxide (3 h) also
colocalize with lysosomal structures. Scale bar, 5 µm.
Supplementary Figure 2 | Akt substrates and functions in ERES, Golgi and
lysosome membranes. (A,C,E) The protein network displays ER- (A), Golgi- (C)
and lysosomes- (E) associated Akt substrates and their interactions, respectively
(according to GO annotation). These networks were obtained using the STRING
database (all interaction sources), requiring at least an intermediate level of
confidence (>0.400). Line thickness indicates the strength of data support while
physical distances between two nodes along an edge in a graph has no meaning.
Colored nodes: query proteins; Empty nodes: proteins of unknown 3D structure;
Filled nodes: some 3D structure is known or predicted. (B,D,F) GO analysis of
ER- (B), Golgi- (D) and lysosomes- (F) associated Akt substrates. Plots show the
top ten Biological Processes GO terms with significant enrichment. Too general,
non-informative or repetitive terms were not included. False Discovery Rate (the
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expected proportion of erroneously rejected null hypotheses among all rejected
ones, where each null hypothesis is related to the association of a given gene with
a particular GO term) and Observed Protein Count (numbers next to each bar) for
each term are shown. The False Discovery Rate bars are presented in log-10
scale. GO categories shown are not mutually exclusive.
Supplementary Figure 3 | Interaction network of Akt substrates which were GO
annotated as related to regulation of autophagy. This network was obtained using
the STRING database (all interaction sources), requiring at least an intermediate
level of confidence for interactions. Line thickness indicates the strength of data
support while physical distances between two nodes along an edge in a graph
has no meaning. Colored nodes: query proteins; Empty nodes: proteins of
unknown 3D structure; Filled nodes: some 3D structure is known or predicted.
Supplementary Table 1 | Predicted S-palmitoylation motifs in different Akt1
homologs. CSS-Palm software was used with a high stringency threshold.
CSS-Palm 4.0 includes a fourth-generation Group-based Prediction System
algorithm and the latest training data set, containing 583 palmitoylation sites from
277 distinct proteins.
Supplementary Movies 1, 2 | In vivo imaging of Akt1 puncta formation. In vivo
imaging of HeLa Kyoto cells constitutively expressing H2B-mCherry (blue) and
transfected with a plasmid coding for Akt1-C344S-YFP (yellow). Cells were
imaged every 20 min. Every time point, a Z Series was performed with 3 z steps of
1 µm for 2 different wavelengths (RFP, exposure: 0.2 s; YFP, exposure: 0.5 s).
Puncta formation in Akt1-C344S-YFP overexpressing cells is accompanied by
nuclear condensation, cell blebbing and fluorescence loss.
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